Milestone Pharmaceuticals Inc.
NASDAQ:MIST
1.47 (USD) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 13.76 | 7.636 | 114.141 | 72.31 | 119.818 | 85.947 | 10.88 |
| Short Term Investments
| 52.243 | 56.949 | 0 | 70 | 0 | 0.029 | 16.032 |
| Cash and Short Term Investments
| 66.003 | 64.585 | 114.141 | 142.31 | 119.818 | 85.976 | 26.912 |
| Net Receivables
| 3.851 | 1.213 | 0.483 | 0.948 | 0.836 | 0.677 | 0.543 |
| Inventory
| 0 | -0.331 | -0.356 | -0.725 | -0.578 | 0 | 0 |
| Other Current Assets
| 3.178 | 6.336 | 4.655 | 6.153 | 2.423 | 1.398 | 0.1 |
| Total Current Assets
| 73.032 | 71.803 | 118.923 | 148.686 | 122.499 | 88.051 | 27.555 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2.194 | 2.68 | 0.926 | 1.288 | 0.929 | 0.03 | 0.035 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | -2.68 | -0.926 | -1.288 | -0.929 | 0 | 0 |
| Total Non-Current Assets
| 2.194 | 2.68 | 0.926 | 1.288 | 0.929 | 0.03 | 0.035 |
| Total Assets
| 75.226 | 74.483 | 119.849 | 149.974 | 123.428 | 88.081 | 27.59 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 3.981 | 2.263 | 4.384 | 4.641 | 4.376 | 2.603 | 0.819 |
| Short Term Debt
| 0.546 | 0.495 | 0.224 | 0.245 | 0.33 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0.056 | 0.004 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.699 | 3.381 | 2.167 | 1.273 | 3.621 | 1.93 | 0.786 |
| Total Current Liabilities
| 7.226 | 6.139 | 6.775 | 6.159 | 8.327 | 4.533 | 1.605 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 49.772 | 1.996 | 0.474 | 0.696 | 0.184 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 1.457 | 0 | 0 | 0 | 0 | 138.758 | 59.104 |
| Total Non-Current Liabilities
| 51.229 | 1.996 | 0.474 | 0.696 | 0.184 | 138.758 | 59.104 |
| Total Liabilities
| 58.455 | 8.135 | 7.249 | 6.855 | 8.511 | 143.291 | 60.709 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 1.623 | 1.633 |
| Common Stock
| 260.504 | 273.9 | 251.901 | 251.682 | 226.245 | 2.039 | 1.228 |
| Retained Earnings
| -326.026 | -266.341 | -206.319 | -163.466 | -113.499 | -58.27 | -35.085 |
| Accumulated Other Comprehensive Income/Loss
| 48.459 | 34.352 | -1.634 | -1.634 | -1.634 | -1.634 | -1.634 |
| Other Total Stockholders Equity
| 33.834 | 24.437 | 68.652 | 56.537 | 3.805 | 1.032 | 0.739 |
| Total Shareholders Equity
| 16.771 | 66.348 | 112.6 | 143.119 | 114.917 | -55.21 | -33.119 |
| Total Equity
| 16.771 | 66.348 | 112.6 | 143.119 | 114.917 | -55.21 | -33.119 |
| Total Liabilities & Shareholders Equity
| 75.226 | 74.483 | 119.849 | 149.974 | 123.428 | 88.081 | 27.59 |